At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 3, 2026 at 16:32 ET
Krystal Biotech filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is routine and contains standard information about voting procedures and meeting logistics. No material changes or activist campaigns are indicated.
- Filing is a definitive proxy statement (DEFA14A) for Krystal Biotech, Inc. (KRYS)
- Document is routine and contains standard voting information
- No indication of activist campaigns, mergers, or significant corporate actions
- Filing appears to be for standard annual meeting procedures
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access